Prof. King is a pioneer in the field of venoms-based drug discovery, in particular the development of peptide therapeutics and bioinsecticides from spider venoms. His work has been instrumental in unravelling the structural and functional complexity of spider venoms, the roles played by different classes of peptide toxins in prey immobilisation, and the mechanism by which spiders evolved complex repertoires of venom peptides. King is the founder of Vestaron Corporation, an agricultural biotechnology company that is developing bee-safe bioinsecticides derived from spider venom. Prof. King’s laboratory at The University of Queensland maintains the largest collection of venoms in the world, comprising more than 650 venoms from ants, assassin bugs, caterpillars, centipedes, cone snails, scorpions, and spiders. Proteomics has become an essential tool in his lab for profiling the often complex venom arsenals of these animals, de novo sequencing of venom peptides, and the elucidation of exotic post-translational modifications employed by venomous animals. Prof. King is former President of the Australian Society for Biophysics, former Chair of the Australian and New Zealand Society for Magnetic Resonance, and he has been an elected member of the Executive Council of the International Society for Toxinology since 2012. He has served on the Editorial Board of numerous journals and is currently Editor-in-Chief of Toxicon.